|
1
|
Taft RJ, Pheasant M and Mattick JS: The
relationship between non-protein-coding DNA and eukaryotic
complexity. Bioessays. 29:288–299. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Iyer MK, Niknafs YS, Malik R, Singhal U,
Sahu A, Hosono Y, Barrette TR, Prensner JR, Evans JR, Zhao S, et
al: The landscape of long noncoding RNAs in the human
transcriptome. Nat Genet. 47:199–208. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fidler IJ, Yano S, Zhang RD, Fujimaki T
and Bucana CD: The seed and soil hypothesis: Vascularisation and
brain metastases. Lancet Oncol. 3:53–57. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ellis LM and Hicklin DJ: VEGF-targeted
therapy: Mechanisms of anti-tumour activity. Nat Rev Cancer.
8:579–591. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang C, Wen Z, Xie J, Zhao Y, Zhao L,
Zhang S, Liu Y, Xue Y and Shi M: MACC1 mediates chemotherapy
sensitivity of 5-FU and cisplatin via regulating MCT1 expression in
gastric cancer. Biochem Biophys Res Commun. 485:665–671. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hombach S and Kretz M: Non-coding RNAs:
Classification, biology and functioning. Adv Exp Med Biol.
937:3–17. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bhan A and Mandal SS: Long noncoding RNAs:
Emerging stars in gene regulation, epigenetics and human disease.
ChemMedChem. 9:1932–1956. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yap KL, Li S, Muñoz-Cabello AM, Raguz S,
Zeng L, Mujtaba S, Gil J, Walsh MJ and Zhou MM: Molecular interplay
of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by
polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell.
38:662–674. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tachibana I, Smith JS, Sato K, Hosek SM,
Kimmel DW and Jenkins RB: Investigation of germline PTEN, p53,
p16(INK4A)/p14(ARF), and CDK4 alterations in familial glioma. Am J
Med Genet. 92:136–141. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shen XH, Qi P and Du X: Long non-coding
RNAs in cancer invasion and metastasis. Mod Pathol. 28:4–13. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nie FQ, Sun M, Yang JS, Xie M, Xu TP, Xia
R, Liu YW, Liu XH, Zhang EB, Lu KH and Shu YQ: Long noncoding RNA
ANRIL promotes non-small cell lung cancer cell proliferation and
inhibits apoptosis by silencing KLF2 and P21 expression. Mol Cancer
Ther. 14:268–277. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen D, Zhang Z, Mao C, Zhou Y, Yu L, Yin
Y, Wu S, Mou X and Zhu Y: ANRIL inhibits p15(INK4b) through the
TGFβ1 signaling pathway in human esophageal squamous cell
carcinoma. Cell Immunol. 289:91–96. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Arita T, Ichikawa D, Konishi H, Komatsu S,
Shiozaki A, Shoda K, Kawaguchi T, Hirajima S, Nagata H, Kubota T,
et al: Circulating long non-coding RNAs in plasma of patients with
gastric cancer. Anticancer Res. 33:3185–3193. 2013.PubMed/NCBI
|
|
14
|
Rupaimoole R and Slack FJ: MicroRNA
therapeutics: Towards a new era for the management of cancer and
other diseases. Nat Rev Drug Discov. 16:203–222. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lin F, Li Y, Yan S, Liu S, Qian W, Shen D,
Lin Q and Mao W: MicroRNA-181a inhibits tumor proliferation,
invasiveness, and metastasis and is downregulated in gastric
cancer. Oncol Res. 22:75–84. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42((Database Issue)): D92–D97. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lewis BP, Shih IH, Jones-Rhoades MW,
Bartel DP and Burge CB: Prediction of mammalian microRNA targets.
Cell. 115:787–798. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Krek A, Grün D, Poy MN, Wolf R, Rosenberg
L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M
and Rajewsky N: Combinatorial microRNA target predictions. Nat
Genet. 37:495–500. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Enright AJ, John B, Gaul U, Tuschl T,
Sander C and Marks DS: MicroRNA targets in Drosophila.
Genome Biol. 5:R12003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Oda I, Shimazu T, Ono H, Tanabe S, Iishi
H, Kondo H and Ninomiya M: Design of Japanese multicenter
prospective cohort study of endoscopic resection for early gastric
cancer using web registry (J-WEB/EGC). Gastric Cancer. 15:451–454.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jim MA, Pinheiro PS, Carreira H, Espey DK,
Wiggins CL and Weir HK: Stomach cancer survival in the United
States by race and stage (2001–2009): Findings from the CONCORD-2
study. Cancer. 123 (Suppl 24):S4994–S5013. 2017. View Article : Google Scholar
|
|
23
|
Song Z, Wu Y, Yang J, Yang D and Fang X:
Progress in the treatment of advanced gastric cancer. Tumour Biol.
39:10104283177146262017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li Y, Lv S, Ning H, Li K, Zhou X, Xv H and
Wen H: Down-regulation of CASC2 contributes to cisplatin resistance
in gastric cancer by sponging miR-19a. Biomed Pharmacother.
108:1775–1782. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wei L, Sun J, Zhang N, Zheng Y, Wang X, Lv
L, Liu J, Xu Y, Shen Y and Yang M: Noncoding RNAs in gastric
cancer: Implications for drug resistance. Mol Cancer. 19:622020.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu Y, Zhang Q, Miao C, Dongol S, Li Y, Jin
C, Dong R, Li Y, Yang X and Kong B: CCNG1 (Cyclin G1) regulation by
mutant-P53 via induction of Notch3 expression promotes high-grade
serous ovarian cancer (HGSOC) tumorigenesis and progression. Cancer
Med. 8:351–362. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Han H, Zhang Z, Yang X, Yang W, Xue C and
Cao X: miR-23b suppresses lung carcinoma cell proliferation through
CCNG1. Oncol Lett. 16:4317–4324. 2018.PubMed/NCBI
|
|
28
|
Ye XX, Liu CB, Chen JY, Tao BH and Zhi-Yi
C: The expression of cyclin G in nasopharyngeal carcinoma and its
significance. Clin Exp Med. 12:21–24. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang D, Sun G, Zhang H, Tian J and Li Y:
Long non-coding RNA ANRIL indicates a poor prognosis of cervical
cancer and promotes carcinogenesis via PI3K/Akt pathways. Biomed
Pharmacother. 85:511–516. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen G, Shen ZL, Wang L, Lv CY, Huang XE
and Zhou RP: hsa-miR-181a-5p expression and effects on cell
proliferation in gastric cancer. Asian Pac J Cancer Prev.
14:3871–3875. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lu Z, Luo T, Pang T, Du Z, Yin X, Cui H,
Fang G and Xue X: MALAT1 promotes gastric adenocarcinoma through
the MALAT1/miR-181a-5p/AKT3 axis. Open Biol. 9:1900952019.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ghaedi H, Mozaffari MAN, Salehi Z, Ghasemi
H, Zadian SS, Alipoor S, Hadianpour S and Alipoor B: Co-expression
profiling of plasma miRNAs and long noncoding RNAs in gastric
cancer patients. Gene. 687:135–142. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Capizzi M, Strappazzon F, Cianfanelli V,
Papaleo E and Cecconi F: MIR7-3HG, a MYC-dependent modulator
of cell proliferation, inhibits autophagy by a regulatory loop
involving AMBRA1. Autophagy. 13:554–566. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lan WG, Xu DH, Xu C, Ding CL, Ning FL,
Zhou YL, Ma LB, Liu CM and Han X: Silencing of long non-coding RNA
ANRIL inhibits the development of multidrug resistance in gastric
cancer cells. Oncol Rep. 36:263–270. 2016. View Article : Google Scholar : PubMed/NCBI
|
